Results 21 to 30 of about 1,013,786 (315)

Metastatic Medulloblastoma [PDF]

open access: yesCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1974
SUMMARY:The incidence of metastatic medulloblastoma is probably greater than the thirteen documented patients. Case reports of metastatic medulloblastoma must be carefully analysed. We have added two cases which conform to Weiss’ criteria for metastatic disease. The direction and factors influencing spread have been discussed.
D, Parkinson, R T, Ross, C B, Shields
openaire   +2 more sources

Role of gemcitabine in the treatment of advanced and metastatic breast cancer [PDF]

open access: yes, 2003
Gemcitabine is an antimetabolite drug with proven antitumor activity and tolerability in metastatic breast cancer. In a total of nine studies, gemcitabine monotherapy has reached response rates of up to 37% in the first-line setting, 26% in the second ...
Heinemann, Volker
core   +1 more source

Hepatic metastatic niche: from normal to pre-metastatic and metastatic niche

open access: yesTumor Biology, 2015
Liver is the organ responsible for hematopoiesis during fetal life, which is also a target organ of metastasis for several cancers. In order to recognize the hepatic metastatic changes, obtain a better grasp of cancer prevention, treatment, and inhibition mode of hepatic metastasis progression, we investigate the changes and transformation of normal ...
Azizidoost, Shirin   +5 more
openaire   +3 more sources

Cancer‐directed surgery in patients with metastatic cancer: A systematic review and meta‐analysis of randomized evidence

open access: yesCancer Medicine, 2023
Purpose To assess the impact of primary‐site surgery plus systemic therapy compared to systemic therapy alone on overall survival in common metastatic cancer types.
Mary Kathryn Abel   +7 more
doaj   +1 more source

Weekly irinotecan in a patient with metastatic colorectal cancer on hemodialysis due to chronic renal failure [PDF]

open access: yes, 2002
Background: The cytotoxic treatment of patients suffering from advanced or metastatic cancer undergoing hemodialysis due to chronic renal failure still remains a problem, since for those patients pharmacokinetic and pharmacodynamic data on most cytotoxic
Stemmler, J.   +4 more
core   +1 more source

Metastatic rectal cancer in the ampulla of Vater: A unique case

open access: yesCancer Reports, 2022
Background A metastatic lesion located in the ampulla of Vater is considered extremely rare, with only 32 cases reported globally. Case A 65‐year‐old patient was primarily diagnosed with a rectal adenocarcinoma.
Athina A. Samara   +8 more
doaj   +1 more source

Hormone receptor-positive, HER2-negative, metastatic breast cancer responded well to abemaciclib and exemestane after palbociclib and fulvestrant failure: A case report and literature review

open access: yesFrontiers in Oncology, 2023
There is uncertainty regarding the usefulness of CDK4/6-inhibitor-based therapy for hormone receptor positive (HR+), human epidermal grow factor receptor 2 negative (HER2−), metastatic breast cancer (MBC), when CDK4/6 inhibitor treatment had previously ...
Yan Mao   +4 more
doaj   +1 more source

“Metastatic Cancer of Unknown Primary” or “Primary Metastatic Cancer”? [PDF]

open access: yesFrontiers in Oncology, 2020
Cancer of unknown primary (CUP) is an umbrella term used to classify a heterogeneous group of metastatic cancers based on the absence of an identifiable primary tumor. Clinically, CUPs are characterized by a set of distinct features comprising early metastatic dissemination in an atypical pattern, an aggressive clinical course, poor response to empiric
Stefan Kolling   +9 more
openaire   +3 more sources

Prolonged survival of patients receiving trastuzumab beyond disease progression for HER2 overexpressing metastatic breast cancer (MBC) [PDF]

open access: yes, 2005
Background: The aim of this retrospective analysis was to evaluate the impact of trastuzumab-based regimens on the survival of patients with HER2-overexpressing metastatic breast cancer (MBC).
Heinrich, B.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy